Comparative Pharmacology
Head-to-head clinical analysis: LOZOL versus THALITONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LOZOL versus THALITONE.
LOZOL vs THALITONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Thiazide-like diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule of the nephron, reducing plasma volume and extracellular fluid volume; also causes direct vasodilation through modulation of calcium channels.
Thalidone (chlorthalidone) is a thiazide-like diuretic that inhibits sodium-chloride symporter (NCC) in the distal convoluted tubule of the kidney, increasing excretion of sodium, chloride, and water. It also reduces peripheral vascular resistance and has a long duration of action (>24 hours).
Indapamide: Oral, 1.25 mg once daily. May increase to 2.5 mg once daily if no response after 4 weeks.
Oral, 25-100 mg once daily, typically 50 mg daily.
None Documented
None Documented
Terminal half-life: 14-18 hours (mean 16 hours); clinically significant for once-daily dosing
Terminal elimination half-life is 40-60 hours, allowing once-daily dosing.
Renal: 70% unchanged, Biliary/Fecal: 30% as metabolites
Primarily renal (approximately 50% unchanged); biliary/fecal elimination minor (<10%).
Category C
Category C
Thiazide-like Diuretic
Thiazide-like Diuretic